Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;68(4):292-296.
doi: 10.1007/s00105-017-3935-2.

[Adjuvants]

[Article in German]
Affiliations
Review

[Adjuvants]

[Article in German]
R Brehler. Hautarzt. 2017 Apr.

Abstract

It is estimated that only 5% of all patients who can principally benefit from specific immunotherapy (SIT) undergo this treatment. SIT represents the only curative treatment for allergic disorders and efficacy has been demonstrated with various allergens. There is an urgent demand for the development of safe preparations with enhanced efficacy achievable by only a few administrations. Adjuvants are pharmacological or immunological acting molecules modifying the specific immunological response to allergens. In vaccine technology, adjuvants are broadly used to enhance immunogenicity of highly purified antigens with low immune stimulating activity. Adjuvants may target to a retarded allergen release, a modulation of the immune system, or can be used as vector systems to transport allergens and adjuvants effectively to target cells.

Keywords: Allergen immunotherapy; Allergy; Antigens; Immunostimulation; Vector systems.

PubMed Disclaimer

References

    1. Allergy Asthma Proc. 2016 Jul;37(4):324-34 - PubMed
    1. FASEB J. 2012 Mar;26(3):1272-9 - PubMed
    1. J Allergy Clin Immunol. 2015 Mar;135(3):737-44.e8 - PubMed
    1. Allergy. 2017 Mar;72 (3):435-443 - PubMed
    1. Vaccine. 2014 Jul 16;32(33):4234-42 - PubMed

LinkOut - more resources